FrancophonIA/ELRC3.0 huggingface dataset:
English: - shortness of breath, inflammation of the lungs - inflammations of the pancreas (severe pain in the stomach or back) - liver problems, kidney failure - severe rashes or skin peeling (at the same time you may feel unwell or develop a fever) - abnormal muscle breakdown (you may feel pain or weakness in your muscles) which can lead to kidney problems - swollen glands, blood disorders (reduction in the number of blood cells, which can make infection more likely and can make you look pale, feel tired and feverish, and bruise more easily) - decreased sweating, overheating - problems with your urine - increased blood levels of creatine phosphokinase or urea which can be seen in a blood test - abnormal results from liver function tests - glaucoma, which is a blockage of fluid in the eye causing increased pressure in the eye.
Estonian: • näärmete turse, verehäired (vererakkude arvu vähenemine, mille tagajärjel võivad tekkida kergemini infektsioonid ning võite olla kahvatu, tunda väsimust või palavikku või teil tekivad kergemini verevalumid);
English: If you are a woman of childbearing age you must use adequate contraception while taking, and for one month after stopping, Zonisamide Mylan.
Estonian: Fertiilses eas naised peavad ravi ajal ja ühe kuu jooksul pärast ravi lõpetamist Zonisamide Mylan'iga kasutama tõhusaid rasestumisvastaseid vahendeid.
English: Zonisamide should not be used as co-medication in paediatric patients with other carbonic anhydrase inhibitors such as topiramate and acetazolamide (see section 4.4: Paediatric population).
Estonian: Zonisamiidi ei tohi kasutada samaaegse ravimina lastel, kes kasutavad muid süsiniku anhüdraasi inhibiitoreid, nagu topiramaat ja atsetasoolamiid (vt lõik 4.4 „Lapsed”).
English: Treatment Regimen
Estonian: Retseptiravim
English: Zonisamide Mylan 25 mg hard capsules zonisamide
Estonian: Zonisamide Mylan 25 mg kõvakapslid zonisamiid
English: Zonisamide Mylan 100 mg hard capsules zonisamide
Estonian: Zonisamide Mylan 100 mg kõvakapslid zonisamiid
English: The other ingredients are: - capsule contents: microcrystalline cellulose, hydrogenated vegetable oil and sodium laurilsulfate - capsule shell: gelatin and titanium dioxide (E171) - printing ink: shellac and iron oxide red (E172)
Estonian: Teised koostisosad on järgmised - Kapsli sisu: mikrokristalliline tselluloos, hüdrogeenitud taimeõli ja naatriumlaurüülsulfaat.
English: Each capsule contains 100 mg of zonisamide.
Estonian: Üks kapsel sisaldab 100 mg zonisamiidi.
English: 100 mg/day (in two divided doses)
Estonian: 100 mg ööpäevas (jagatuna kaheks annuseks)
English: Zonisamide Mylan 25 mg and 50 mg hard capsules
Estonian: Zonisamide Mylan 25 mg ja 50 mg kõvakapslid
English: 200 mg/day (once a day)
Estonian: 200 mg ööpäevas (üks kord ööpäevas)
English: Each capsule contains 25 mg of zonisamide.
Estonian: Üks kapsel sisaldab 25 mg zonisamiidi.
English: The risk of birth defect is increased by factor 2 to 3 in the offspring of mothers treated with an antiepileptic medicinal product.
Estonian: Epilepsiaravimitega ravitavate emade järglastel on väärarengute tekkimise oht 2...3 korda suurem.
English: Zonisamide Mylan 50 mg hard capsules zonisamide
Estonian: Zonisamide Mylan 50 mg kõvakapslid zonisamiid
English: When your child is taking Zonisamide Mylan: keep your child cool especially in hot weather your child must avoid heavy exercise especially when the weather is hot give your child plenty of cold water to drink your child must not take these medicines: carbonic anhydrase inhibitors (like topiramate and acetazolamide), and anticholinergic agents (like clomipramine, hydroxyzine, diphenhydramine, haloperidol, imipramine and oxybutynin).
Estonian: • ei tohi teie laps võtta järgmisi ravimeid: süsiniku anhüdraasi inhibiitorid (näiteks topiramaat ja atsetasoolamiid) ja antikolinergilised ained (näiteks klomipramiin, hüdroksüsiin, difenhüdramiin, haloperidool, imipramiin ja oksübutüniin).
English: - The recommended daily dose is between 300 mg and 500 mg. - Some people respond to lower doses.
Estonian: • soovitatav annus on 300 mg kuni 500 mg ööpäevas;
English: There is no need for dose adjustment with any of the AEDs including CYP3A4 inducers.
Estonian: Epilepsiaravimite, sealhulgas CYP3A4 indutseerivate ainete kasutamisel ei ole annuse kohandamine vajalik.
English: Contact your doctor immediately if you: - have difficulty breathing, a swollen face, lips or tongue, or a severe skin rash as these symptoms may indicate that you are having a severe allergic reaction - have signs of overheating - high body temperature but little or no sweating, rapid heartbeat and breathing, muscle cramps, and confusion - have thoughts of harming or killing yourself.
Estonian: • hingamisraskused, näo, huulte või keele turse või tugev nahalööve, sest need sümptomid võivad näidata, et teil on tekkinud raske allergiline reaktsioon;
English: 100 mg/day (once a day)
Estonian: 100 mg ööpäevas (üks kord ööpäevas)
English: Each capsule contains 50 mg of zonisamide.
Estonian: Üks kapsel sisaldab 50 mg zonisamiidi.
English: Hepatic dysfunction
Estonian: Kehakaalu alanemine
English: Each hard capsule contains 100 mg zonisamide.
Estonian: Üks kõvakapsel sisaldab 100 mg zonisamiidi.
English: Dizziness
Estonian: Müoopia
English: Zonisamide Mylan 25 mg hard capsules have a white body and a white cap, marked ‘Z 25' in black and contain a white/almost white powder.
Estonian: Kuidas Zonisamide Mylan välja näeb ja pakendi sisu Zonisamide Mylan 25 mg kõvakapslitel on valge kapslikeha ja valge kapslikaas, neile on trükitud mustaga ‘Z 25' ja sisaldavad valgetvõi peaaegu valget pulbrit.
English: Withdrawal
Estonian: Eritumine
English: Zonisamide must not be used during pregnancy unless clearly necessary and only if the potential benefit is considered to justify the risk to the foetus.
Estonian: Seda võib kasutada vaid sel juhul, kui võimalikku kasu peetakse põhjendatuks, arvestades lootel avalduvat riski.
English: Cases of decreased sweating and elevated body temperature have been reported mainly in paediatric patients.
Estonian: Põhiliselt lastel on esinenud higistamise vähenemist ja kehatemperatuuri tõusu.
English: 300 mg/day (once a day)
Estonian: 300 mg ööpäevas (üks kord ööpäevas)
English: ANNEX I
Estonian: Märkus: a.
English: Be especially careful while driving or operating machinery if Zonisamide Mylan affects you in this way.
Estonian: Kui Zonisamide Mylan avaldab teile sellist mõju, peate olema autojuhtimisel ja masinatega töötamisel eriti ettevaatlik.
English: Each hard capsule contains 25 mg zonisamide.
Estonian: Üks kõvakapsel sisaldab 25 mg zonisamiidi.
English: Each hard capsule contains 50 mg zonisamide.
Estonian: Üks kõvakapsel sisaldab 50 mg zonisamiidi.
English: Fatigue Pyrexia Irritability
Estonian: Afektne labiilsus Ärevus
English: INFORMATION IN BRAILLE Zonisamide Mylan 25 mg
Estonian: Zonisamide Mylan 25 mg
English: When you take Zonisamide Mylan with other antiepileptic medicines: - The starting dose is 50 mg daily taken in two equal doses of 25 mg. - This may be increased by up to 100 mg at intervals of one to two weeks.
Estonian: • algannus on 50 mg ööpäevas, jagatuna kaheks võrdseks 25 mg annuseks;
English: Specialist advice should be given to women treated with zonisamide who are of childbearing potential.
Estonian: Zonisamiidiga ravitavad fertiilses eas naised peavad konsulteerima eriarstiga.
English: EXPIRY DATE
Estonian: Tiitrimisfaas
English: A small number of people being treated with anti epileptics such as Zonisamide Mylan have had thoughts of harming or killing themselves- have pain in your muscles or a feeling of weakness, as this may be a sign of abnormal muscle breakdown which can lead to kidney problems - get a sudden pain in your back or stomach, have pain on urinating (passing water) or notice blood in your urine, as this may be a sign of kidney stones - develop visual problems such as eye pain or blurred vision while taken zonisamide.
Estonian: • äkki valu seljas või maos, valulik urineerimine või vere sisaldumine uriinis, sest see võib olla neerukivide tekkimise näht;
English: Cholecystitis Cholelithiasis
Estonian: Zonisamiid Karbamasepiin
English: Contact your doctor as soon as possible if you: - have an unexplained skin rash, as this could develop into a more severe skin rash or skin peeling - feel unusually tired or feverish, have a sore throat, swollen glands, or find that you bruise more easily, as this may mean you have a blood disorder - have signs of increased acid level in the blood- headaches, drowsiness, shortness of breath and loss of appetite.
Estonian: JÄRGMISTEL JUHTUDEL VAJAB LAPS KIIRESTI ARSTIABI Kui nahk tundub väga kuum ja laps higistab vähe või ei higista üldse, lapsel tekib segasus, tekivad lihaskrambid või südametegevuse või hingamise kiirenemine:
English: • adjunctive therapy in the treatment of partial seizures, with or without secondary generalisation, in adults, adolescents, and children aged 6 years and above.
Estonian: Zonisamiid on näidustatud o monoteraapiana esmakordselt diagnoositud epilepsiaga täiskasvanutel, kellel esinevad partsiaalsed epilepsiahood sekundaarse generaliseerumisega või ilma (vt lõik 5.1); o adjuvantravina täiskasvanutel, noorukitel, ning lastel vanuses 6 aastat ja vanemad, kellel esinevad partsiaalsed epilepsiahood sekundaarse generaliseerumisega või ilma.
English: Do not reduce your dose or stop your medicine unless your doctor tells you to. - If your doctor advises you to stop taking Zonisamide Mylan your dose will be reduced gradually to lower the risk of more seizures.
Estonian: • Kui arst soovitab teil ravi lõpetada, vähendatakse Zonisamide Mylan'i annust järk-järgult, et vähendada epilepsiahoogude sagenemise riski.
English: Keep this medicine out of the sight and reach of children.
Estonian: Kuidas Zonisamide Mylan'it säilitada Hoidke seda ravimit laste eest varjatud ja kättesaamatus kohas.
English: Fatigue Influenza-like illness
Estonian: Väsimus Gripisarnane haigestumine Püreksia Perifeerne turse
English: The full EPAR for Ingelvac CircoFLEX can be found on the Agency's website: ema.europa.eu/Find medicine/Veterinary medicines/European public assessment reports.
Estonian: Euroopa avaliku hindamisaruande täistekst vaktsiini Ingelvac CircoFLEX kohta on ameti veebilehel: ema.europa.eu/Find medicine/Veterinary medicines/European public assessment reports.
English: This summary was last updated in March 2017.
Estonian: Kokkuvõtte viimane uuendus: 03-2017.
English: The European Commission granted a marketing authorisation valid throughout the EU for Ingelvac CircoFLEX on 13 February 2008.
Estonian: Euroopa Komisjon andis vaktsiini Ingelvac CircoFLEX müügiloa, mis kehtib kogu Euroopa Liidu territooriumil, 13. veebruaril 2008.
English: porcine circovirus type 2 vaccine
Estonian: sigade tsirkoviiruse tüüp 2 vaktsiin
English: The Agency's Committee for Medicinal Products for Veterinary Use (CVMP) concluded that Ingelvac CircoFLEX's benefits are greater than its risks and recommended that it be approved for use in the EU.
Estonian: Veterinaarravimite komitee järeldas, et vaktsiini Ingelvac CircoFLEX kasulikkus on suurem kui sellega kaasnevad riskid, ja soovitas vaktsiini kasutamise Euroopa Liidus heaks kiita.
English: response will help to protect the pig against the disease caused by this virus.
Estonian: Aktiivne immuunvastus aitab kaitsta siga haiguse eest, mida viirus põhjustab.
English: The most common side effect with Ingelvac CircoFLEX (which may affect more than 1 in 10 animals) is a mild and short lived increase in body temperature on the day of vaccination.
Estonian: Vaktsiini Ingelvac CircoFLEX kõige sagedamad kõrvalnähud (võivad esineda enam kui 1 loomal 10st) on kerge ja mööduv kehatemperatuuri tõus vaktsineerimispäeval.
English: The trials showed that vaccination of pigs with Ingelvac CircoFLEX reduced weight loss in the piglets.
Estonian: Uuringud näitasid, et sigade vaktsineerimine vaktsiiniga Ingelvac CircoFLEX vähendas põrsastel kaalulangust.
English: What is Ingelvac CircoFLEX and what is it used for?
Estonian: Mis on Ingelvac CircoFLEX ja milleks seda kasutatakse?
English: It also reduced the levels of PCV2 in the blood, clinical signs of PCV2 infection, the number of runts and death rates.
Estonian: Ühtlasi vähendas see PCV2 sisaldust veres, PCV2 nakkuse kliinilisi nähtusid, kasvupeetusega sigade arvu ja suremust.
English: For practical information about using Ingelvac CircoFLEX, animal owners or keepers should read the package leaflet or contact their veterinarian or pharmacist.
Estonian: Kui loomaomanikud või -pidajad vajavad vaktsiini Ingelvac CircoFLEX kasutamise praktilisi nõuandeid, peavad nad lugema pakendi infolehte või pöörduma oma veterinaararsti või apteekri poole.
English: The withdrawal period for meat from pigs treated with Ingelvac CircoFLEX is ‘zero days', which means there is no mandatory waiting time.
Estonian: Vaktsiiniga Ingelvac CircoFLEX ravitud sigade liha keeluaeg on 0 päeva, mis tähendab, et keeluaega ei ole.
English: Ingelvac CircoFLEX is a vaccine used to protect pigs from the two weeks of age against porcine circovirus type 2 (PCV2).
Estonian: Ingelvac CircoFLEX on vaktsiin, mida kasutatakse vähemalt 2-nädalaste sigade kaitsmiseks sigade tsirkoviiruse tüüp 2 (PCV2) eest.
English: Why is Ingelvac CircoFLEX approved?
Estonian: Miks Ingelvac CircoFLEX heaks kiideti?
English: It is not intended to provide practical advice on how to use Ingelvac CircoFLEX.
Estonian: Hindamisaruandes ei anta vaktsiini Ingelvac CircoFLEX kasutamise praktilisi nõuandeid.
English: Ingelvac CircoFLEX contains small amounts of a protein from PCV2.
Estonian: Ingelvac CircoFLEX sisaldab vähesel hulgal PCV2 valku.
English: Ingelvac CircoFLEX is a vaccine.
Estonian: Ingelvac CircoFLEX on vaktsiin.
English: Ingelvac CircoFLEX contains the active substance porcine circovirus type 2 ORF2 protein.
Estonian: Ingelvac CircoFLEX sisaldab toimeainena sigade tsirkoviiruse tüüp 2 ORF2 valku.
English: This is a summary of the European public assessment report (EPAR) for Ingelvac CircoFLEX.
Estonian: See on vaktsiini Ingelvac CircoFLEX Euroopa avaliku hindamisaruande kokkuvõte.
English: What are the risks associated with Ingelvac CircoFLEX?
Estonian: Mis riskid vaktsiiniga Ingelvac CircoFLEX kaasnevad?
English: Ingelvac CircoFLEX has been studied in a number of trials involving pigs of various breeds.
Estonian: Vaktsiini Ingelvac CircoFLEX uuriti mitmes uuringus eri tõugu sigadel.
English: For the full list of restrictions and all side effects reported with Ingelvac CircoFLEX, see the package leaflet.
Estonian: Vaktsiini Ingelvac CircoFLEX kohta teatatud piirangute ja kõrvalnähtude täielik loetelu on pakendi infolehel.
English: When a pig is given the vaccine, the pig's immune system recognises the protein as ‘foreign' and reacts by building up an active immune response.
Estonian: Kui seale antakse vaktsiini Ingelvac CircoFLEX, peab sea immuunsüsteem valku võõraks ja tekitab sellele reaktsioonina immuunvastuse.
English: How does Ingelvac CircoFLEX work?
Estonian: Kuidas Ingelvac CircoFLEX toimib?
English: How is Ingelvac CircoFLEX used?
Estonian: Kuidas vaktsiini Ingelvac CircoFLEX kasutatakse?
English: Ingelvac CircoFLEX is available as a suspension for injection and can only be obtained with a prescription.
Estonian: Vaktsiini Ingelvac CircoFLEX turustatakse süstesuspensioonina ja see on retseptivaktsiin.
English: Other information about Ingelvac CircoFLEX:
Estonian: Muu teave vaktsiini Ingelvac CircoFLEX kohta
English: In the future, the immune system will be able to react against the virus more quickly when it is exposed to the virus.
Estonian: Kui immuunsüsteem puutub viirusega
English: What benefits of Ingelvac CircoFLEX have been shown in studies?
Estonian: Milles seisneb uuringute põhjal vaktsiini Ingelvac CircoFLEX kasulikkus?
English: Only a few families with this disease are known worldwide.
Estonian: Kogu maailmas on teada vaid mõned selle haiguse all kannatavad perekonnad.
English: The following information is intended for healthcare professionals only:
Estonian: Järgnev informatsioon on mõeldud ainult tervishoiutöötajale:
English: t½ (days)
Estonian: t½ (ööpäevad)
English: Stability after first opening:
Estonian: Stabiilsus pärast esmast avamist:
English: Read this section carefully.
Estonian: Lugege see lõik tähelepanelikult läbi.
English: What kind of monitoring is required during the infusion?
Estonian: Missugune jälgimine on infusiooni ajal vajalik?
English: In certain circumstances, special precautions may be necessary.
Estonian: Teatud olukordades võib osutuda vajalikuks eriliste ettevaatusabinõude rakendamine.
English: Contains 3 vials.
Estonian: Sisaldab 3 viaali.
English: • you are receiving Privigen for the first time or after a long break in treatment (e.g. several months).
Estonian: • saate Privigeni esimest korda või pika ravipausi (nt mitu kuud) järel.
English: The approximate percentage of IgG subclasses is as follows:
Estonian: IgG alaklasside ligikaudne protsentuaalne osakaal on järgmine:
English: However, true allergic reactions are rare.
Estonian: Tõelised allergilised reaktsioonid esinevad siiski harva.
English: Transmissible agents
Estonian: Ülekantavad agensid
English: It is usually prepared from pooled plasma from not fewer than 1,000 donors.
Estonian: Enamasti valmistatakse ravim mitte vähem kui 1000 doonorilt kogutud plasmast.
English: All other patients should be observed for at least 20 minutes after administration.
Estonian: Kõiki teisi patsiente tuleb jälgida vähemalt 20 minutit pärast manustamist.
English: Other medicines and Privigen
Estonian: Muud ravimid ja Privigen
English: Examples of such circumstances are:
Estonian: Sellised olukorrad on järgmised:
English: If this happens, you should not drive or use machines until these effects have disappeared.
Estonian: Kui nii juhtub, ei tohi autot juhtida või masinaid käsitseda enne, kui nähud on möödunud.
English: Thus, also your baby can receive the protective antibodies.
Estonian: Seega saab ka teie laps neid kaitsvaid antikehi.
English: Such vaccinations should be postponed for at least 3 months after the last infusion of Privigen.
Estonian: Need vaktsinatsioonid tuleb edasi lükata vähemalt 3 kuuks pärast Privigeni viimast infusiooni.
English: Of these, 72 completed the 12 months of treatment.
Estonian: Neist 72 läbis 12 kuu pikkuse ravi.
English: IgA ≤ 25 micrograms.
Estonian: IgA ≤ 25 mikrogrammi.
English: The half-life may vary from patient to patient.
Estonian: Poolväärtusaeg võib olla patsienditi erinev.
English: If insufficient treatment effect is seen after 6 months, the treatment should be discontinued.
Estonian: Kui 6 kuu möödudes täheldatakse ebapiisavat ravitoimet, tuleb ravi lõpetada.
English: Overdose is very unlikely to occur because Privigen is usually administered under medical supervision.
Estonian: Üleannustamine on väga vähetõenäoline, sest Privigeni manustatakse tavaliselt meditsiinilise järelevalve all.
English: Which circumstances increase the risk of having side effects?
Estonian: Millised asjaolud suurendavad kõrvaltoimete riski?
English: Solution for infusion (10%)
Estonian: Infusioonilahus (10%)
English: IgG and IgG complexes are broken down in the cells of the reticuloendothelial system.
Estonian: IgG ja IgG-kompleksid lagundatakse retikuloendoteliaalsüsteemi rakkudes.
English: After receiving Privigen, the efficacy of certain vaccinations may be impaired.
Estonian: Pärast Privigeni manustamist võib olla pärsitud teatud vaktsiinide tõhusus.
English: One ml contains:
Estonian: 1 ml sisaldab:
English: 9 patients responded after receiving the initial induction dose by week 4, 16 patients responded by week 10.
Estonian: 9 patsienti reageeris pärast esmase induktsioonannuse saamist 4. nädalaks, 16 patsienti reageeris 10. nädalaks.
English: L-proline is a physiological, nonessential amino acid.
Estonian: L-proliin on füsioloogiline mitteessentsiaalne aminohape.
English: • You have or had previously problems with your kidneys or take medicinal products that may harm your kidneys (nephrotoxic medicinal products).
Estonian: • Teil on või on varem olnud probleeme neerudega või kasutate ravimeid, mis võivad teie neere kahjustada (nefrotoksilised ravimid).
English: If you tolerate this well, your doctor can gradually increase the infusion rate.
Estonian: Kui talute seda hästi, võib arst infusioonikiirust järk-järgult suurendada.
English: Your doctor will calculate the correct dose for you taking into account your weight, the specific circumstances listed under section 2 “Warnings and precautions” and response to treatment.
Estonian: Teie arst arvutab välja õige annuse, võttes arvesse teie kehamassi, lõigus 2 „Hoiatused ja ettevaatusabinõud” nimetatud spetsiifilisi asjaolusid ja ravile reageerimist.
English: This is an extremely rare disorder.
Estonian: See on äärmiselt harvaesinev haigus.
English: Privigen is isotonic, with an approximate osmolality of 320 mOsmol/kg.
Estonian: Privigen on isotooniline ja selle ligikaudne osmolaalsus on 320 mOsmol/kg.
English: The two CIDP studies were performed with 28 and 207 patients, respectively.
Estonian: Kahes CIDP uuringus osales vastavalt 28 ja 207 patsienti.
English: This medicinal product must not be mixed with other medicinal products, diluents, or solvents except those mentioned in section 6.6.
Estonian: Seda ravimpreparaati ei tohi segada teiste ravimitega, lahjenditega ega lahustitega, välja arvatud nendega, mis on loetletud lõigus 6.6.
English: Although limited data is available, it is expected that the same warnings, precautions and risk factors apply to the paediatric population.
Estonian: Kuigi kasutada on piiratud andmed, eeldatakse, et samad hoiatused, ettevaatusabinõud ja riskitegurid kehtivad ka laste kohta.
English: They can occur in patients with anti-IgA antibodies.
Estonian: Need võivad esineda IgA-vastaste antikehadega patsientidel.
English: Secondary immunodeficiencies (as defined in 4.1)
Estonian: Sekundaarne immuunpuudulikkus (määratletud lõigus 4.1)
English: There are two alternative treatment schedules:
Estonian: Kasutada võib kahte alternatiivset raviskeemi:
English: The treatment effect should be evaluated after each cycle.
Estonian: Ravitoimet tuleb hinnata pärast iga tsüklit.
English: This medicinal product must not be mixed with other medicinal products except those mentioned in the section below.
Estonian: Seda ravimpreparaati ei tohi segada teiste ravimitega, välja arvatud käesolevas lõigus allpool mainitutega.
English: Tell your doctor or healthcare professional if you are using, have recently used or might use any other medicines.
Estonian: Teatage oma arstile või tervishoiutöötajale, kui te kasutate või olete hiljuti kasutanud või kavatsete kasutada mis tahes muid ravimeid.
English: • You receive this medicine in high doses either on 1 day or over several days and you have a blood group A, B or AB and/or you have an underlying inflammatory condition.
Estonian: • Te saate seda ravimit suures annuses kas ühel päeval või mitme päeva jooksul ja teil on veregrupp A, B või AB ja/või teil on kaasuv põletikuline haigus.
English: Privigen does not contain sucrose, maltose or glucose.
Estonian: Privigen ei sisalda sahharoosi, maltoosi ega glükoosi.
English: If, in spite of this, you receive more Privigen than you should, your blood may become too thick (hyperviscous) which might increase the risk of developing blood clots.
Estonian: Sellest hoolimata võib juhul, kui teile manustatakse rohkem Privigeni kui ette nähtud, teie veri muutuda liiga paksuks (hüperviskoosseks), mis võib suurendada verehüüvete tekimise riski.
English: Although Privigen does not contain sugar, it may be diluted with a special sugar solution (5% glucose), which could affect your blood sugar level.
Estonian: Kuigi Privigen ei sisalda suhkrut, võib seda lahjendada spetsiaalses suhkrulahuses (5% glükoos), mis võib mõjutada teie veresuhkru taset.
English: The mechanism of action in indications other than replacement therapy is not fully elucidated, but includes immunomodulatory effects.
Estonian: Toimemehhanism teistel näidustustel kui asendusravi kasutamisel ei ole täielikult välja selgitatud, kuid sisaldab immunomoduleerivaid toimeid.
English: Stability after dilution:
Estonian: Stabiilsus pärast lahjendamist: